Pancreatic injury following immune checkpoint inhibitors: A systematic review and meta-analysis
Background: Pancreatic injury (pancreatitis, amylase/lipase elevation) is a rare adverse event of immune checkpoint inhibitors (ICIs). With the high number of clinical studies on ICIs, the incidence and characteristics of associated pancreatic injury (PI) need to be reevaluated.Methods: A systematic...
Main Authors: | Tian Zhang, Yi Wang, Chunhui Shi, Xiaochun Liu, Shangbin Lv, Xin Wang, Weihong Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.955701/full |
Similar Items
-
Pancreatic adverse events of immune checkpoint inhibitors therapy for solid cancer patients: a systematic review and meta-analysis
by: Zhe Zhao, et al.
Published: (2023-06-01) -
Pancreatic adverse events in patients treated with immune checkpoint inhibitors
by: Caroline Hana, et al.
Published: (2023-03-01) -
Immune checkpoint inhibitor-related pancreatitis: What is known and what is not
by: Jiang Chunyan, et al.
Published: (2023-06-01) -
Immunotherapy-Associated Pancreatic Adverse Events: Current Understanding of Their Mechanism, Diagnosis, and Management
by: Ya Liu, et al.
Published: (2021-02-01) -
Dose dependence of treatment-related adverse events for immune checkpoint inhibitor therapies: a model-based meta-analysis
by: Boris Shulgin, et al.
Published: (2020-01-01)